To date, there is no known cure for Alzheimer's Disease. Current drug treatments offer modest symptom relief, but none of the medications is known to delay or halt the progression of the disease.

CARC's goal is to increase knowledge of mechanisms, diagnosis, and psychiatric treatment of mental disorders through clinical research.

The Douglas shares its knowledge with students, staff members, researchers, mental health professionals, workers, and the general public.

The research of Myra Piat focuses on housing for persons with serious mental illness and recovery from serious mental illness.

Gustavo Turecki investigates the neurobiology of suicide, focusing on the role of genetic risk factors.

The CIUSSS de l’Ouest-de-l’Île-de-Montréal is proud to inaugurate its brand-new Centre for translational research on Mood Disorders and Suicide.

Dr. Serge Gauthier, M.D., FRCPC, an eminent researcher in Alzheimer’s disease, has been appointed to the Order of Canada.

A major Douglas-led project as been awarded a Brain Canada grant. 

Clarification on the news series "Pour en finir avec l’itinérance" published by La Presse, June 12, 2014

Brigitte Kieffer takes office as the new Scientific Director of the Douglas Institute Research Centre January 15